| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostatic Neoplasms | 108 | 2025 | 1798 | 17.360 |
Why?
|
| Magnetic Resonance Imaging | 141 | 2025 | 3639 | 14.120 |
Why?
|
| Prostate | 48 | 2025 | 423 | 10.300 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 37 | 2024 | 298 | 7.230 |
Why?
|
| Contrast Media | 62 | 2024 | 1096 | 5.300 |
Why?
|
| Image Interpretation, Computer-Assisted | 26 | 2025 | 700 | 4.240 |
Why?
|
| Image Enhancement | 27 | 2021 | 565 | 3.470 |
Why?
|
| Prostatic Hyperplasia | 10 | 2021 | 97 | 3.270 |
Why?
|
| Laser Therapy | 9 | 2020 | 151 | 3.250 |
Why?
|
| Male | 244 | 2025 | 45863 | 2.970 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 12 | 2021 | 34 | 2.790 |
Why?
|
| Gadolinium DTPA | 19 | 2017 | 255 | 2.560 |
Why?
|
| Humans | 298 | 2025 | 96105 | 2.270 |
Why?
|
| Middle Aged | 152 | 2025 | 28368 | 2.170 |
Why?
|
| Societies, Medical | 18 | 2024 | 644 | 2.010 |
Why?
|
| Aged | 105 | 2025 | 20968 | 1.980 |
Why?
|
| Tomography, X-Ray Computed | 44 | 2020 | 2777 | 1.970 |
Why?
|
| Image Processing, Computer-Assisted | 17 | 2024 | 1319 | 1.760 |
Why?
|
| Sensitivity and Specificity | 43 | 2020 | 2039 | 1.750 |
Why?
|
| Prostatectomy | 20 | 2023 | 480 | 1.740 |
Why?
|
| Image-Guided Biopsy | 10 | 2025 | 82 | 1.740 |
Why?
|
| Liver Neoplasms | 11 | 2016 | 793 | 1.570 |
Why?
|
| Retrospective Studies | 51 | 2025 | 10287 | 1.550 |
Why?
|
| Reproducibility of Results | 35 | 2024 | 2880 | 1.470 |
Why?
|
| Evidence-Based Medicine | 13 | 2024 | 458 | 1.390 |
Why?
|
| Adult | 113 | 2024 | 28721 | 1.390 |
Why?
|
| Crohn Disease | 7 | 2013 | 806 | 1.340 |
Why?
|
| Heart Rate | 13 | 2016 | 518 | 1.220 |
Why?
|
| Radiology | 9 | 2023 | 206 | 1.200 |
Why?
|
| Pregnancy Complications | 7 | 2015 | 356 | 1.180 |
Why?
|
| Liver | 13 | 2020 | 1238 | 1.180 |
Why?
|
| Prostate-Specific Antigen | 10 | 2021 | 346 | 1.170 |
Why?
|
| Neoplasm Staging | 16 | 2024 | 2086 | 1.140 |
Why?
|
| Diagnosis, Differential | 25 | 2024 | 1619 | 1.130 |
Why?
|
| Neoplasm Grading | 13 | 2023 | 404 | 1.100 |
Why?
|
| Neovascularization, Pathologic | 5 | 2015 | 354 | 1.100 |
Why?
|
| Prospective Studies | 26 | 2025 | 4671 | 1.090 |
Why?
|
| Scrotum | 2 | 2024 | 18 | 1.030 |
Why?
|
| Liver Diseases | 7 | 2014 | 249 | 1.030 |
Why?
|
| Imaging, Three-Dimensional | 13 | 2018 | 630 | 1.000 |
Why?
|
| Electrocardiography, Ambulatory | 9 | 2016 | 27 | 0.970 |
Why?
|
| Intestine, Small | 3 | 2013 | 310 | 0.940 |
Why?
|
| Female | 133 | 2024 | 50028 | 0.910 |
Why?
|
| Algorithms | 14 | 2025 | 2015 | 0.900 |
Why?
|
| Appendicitis | 5 | 2015 | 66 | 0.900 |
Why?
|
| Diagnostic Imaging | 11 | 2024 | 475 | 0.900 |
Why?
|
| Artificial Intelligence | 5 | 2025 | 398 | 0.890 |
Why?
|
| Electrocardiography | 24 | 2016 | 522 | 0.850 |
Why?
|
| Biopsy | 17 | 2021 | 1220 | 0.820 |
Why?
|
| Pancreatitis | 4 | 2011 | 94 | 0.810 |
Why?
|
| Aged, 80 and over | 29 | 2020 | 7229 | 0.770 |
Why?
|
| Signal-To-Noise Ratio | 7 | 2025 | 115 | 0.760 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 3 | 2014 | 9 | 0.750 |
Why?
|
| Mobile Applications | 1 | 2023 | 79 | 0.720 |
Why?
|
| Fistula | 2 | 2012 | 42 | 0.710 |
Why?
|
| Abdomen, Acute | 4 | 2013 | 22 | 0.710 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2015 | 341 | 0.690 |
Why?
|
| Cysts | 3 | 2011 | 104 | 0.660 |
Why?
|
| ROC Curve | 11 | 2018 | 797 | 0.650 |
Why?
|
| Multimodal Imaging | 4 | 2018 | 115 | 0.640 |
Why?
|
| Arrhythmias, Cardiac | 5 | 2016 | 206 | 0.630 |
Why?
|
| Hyperthermia, Induced | 1 | 2020 | 75 | 0.620 |
Why?
|
| Observer Variation | 9 | 2016 | 626 | 0.610 |
Why?
|
| Adenocarcinoma | 4 | 2024 | 1215 | 0.610 |
Why?
|
| Spondylitis, Ankylosing | 4 | 2016 | 30 | 0.600 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2021 | 1471 | 0.600 |
Why?
|
| Abnormalities, Multiple | 2 | 2010 | 238 | 0.590 |
Why?
|
| Extracorporeal Shockwave Therapy | 1 | 2018 | 2 | 0.590 |
Why?
|
| Cryotherapy | 1 | 2018 | 30 | 0.580 |
Why?
|
| Neoplasm Invasiveness | 8 | 2024 | 580 | 0.570 |
Why?
|
| Feasibility Studies | 7 | 2019 | 819 | 0.560 |
Why?
|
| Autonomic Nervous System | 8 | 2016 | 68 | 0.560 |
Why?
|
| Urinary Bladder Neoplasms | 5 | 2024 | 382 | 0.560 |
Why?
|
| Autonomic Pathways | 1 | 2017 | 4 | 0.540 |
Why?
|
| Hyperhidrosis | 1 | 2017 | 10 | 0.530 |
Why?
|
| Meglumine | 4 | 2021 | 38 | 0.530 |
Why?
|
| Radiographic Image Enhancement | 5 | 2016 | 467 | 0.530 |
Why?
|
| Abdominal Pain | 5 | 2020 | 145 | 0.530 |
Why?
|
| Ultrasonography | 15 | 2024 | 744 | 0.520 |
Why?
|
| Exercise Test | 3 | 2016 | 178 | 0.510 |
Why?
|
| United States | 22 | 2024 | 7768 | 0.500 |
Why?
|
| Pilot Projects | 6 | 2021 | 938 | 0.500 |
Why?
|
| Pelvic Neoplasms | 3 | 2007 | 45 | 0.490 |
Why?
|
| Reflex, Pupillary | 1 | 2016 | 7 | 0.490 |
Why?
|
| Ablation Techniques | 1 | 2016 | 41 | 0.490 |
Why?
|
| Carcinoma, Transitional Cell | 3 | 2024 | 156 | 0.490 |
Why?
|
| Organometallic Compounds | 4 | 2021 | 148 | 0.490 |
Why?
|
| Appendix | 2 | 2006 | 31 | 0.480 |
Why?
|
| Symptom Assessment | 1 | 2016 | 71 | 0.480 |
Why?
|
| Ultrasonography, Interventional | 4 | 2017 | 125 | 0.480 |
Why?
|
| Prostatitis | 1 | 2015 | 14 | 0.470 |
Why?
|
| Calcinosis | 2 | 2015 | 232 | 0.470 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2015 | 70 | 0.460 |
Why?
|
| Common Bile Duct Diseases | 1 | 2015 | 9 | 0.460 |
Why?
|
| Predictive Value of Tests | 17 | 2024 | 1805 | 0.460 |
Why?
|
| Pregnancy | 14 | 2024 | 3240 | 0.460 |
Why?
|
| Common Bile Duct | 1 | 2015 | 19 | 0.450 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2016 | 149 | 0.450 |
Why?
|
| Recovery of Function | 2 | 2016 | 348 | 0.440 |
Why?
|
| Cystic Duct | 1 | 2014 | 5 | 0.440 |
Why?
|
| Gallbladder | 1 | 2014 | 33 | 0.430 |
Why?
|
| Cholecystitis, Acute | 1 | 2014 | 9 | 0.430 |
Why?
|
| Coronary Artery Disease | 3 | 2010 | 394 | 0.430 |
Why?
|
| Atrial Fibrillation | 6 | 2021 | 392 | 0.430 |
Why?
|
| Practice Guidelines as Topic | 6 | 2019 | 1096 | 0.430 |
Why?
|
| Anatomic Landmarks | 1 | 2014 | 31 | 0.420 |
Why?
|
| Ejaculation | 1 | 2014 | 9 | 0.420 |
Why?
|
| Abdomen | 3 | 2012 | 127 | 0.410 |
Why?
|
| Behcet Syndrome | 5 | 2000 | 15 | 0.410 |
Why?
|
| Neoplasm, Residual | 3 | 2024 | 195 | 0.410 |
Why?
|
| Abdominal Abscess | 2 | 2011 | 23 | 0.410 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2014 | 108 | 0.400 |
Why?
|
| Treatment Outcome | 17 | 2024 | 9175 | 0.400 |
Why?
|
| Pancreas | 4 | 2013 | 264 | 0.390 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 3 | 2020 | 48 | 0.390 |
Why?
|
| Seminal Vesicles | 1 | 2013 | 39 | 0.390 |
Why?
|
| Biomarkers, Tumor | 5 | 2018 | 1670 | 0.390 |
Why?
|
| Pancreatic Diseases | 2 | 2011 | 59 | 0.380 |
Why?
|
| Exercise | 1 | 2016 | 354 | 0.380 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2012 | 325 | 0.380 |
Why?
|
| Tissue Array Analysis | 1 | 2012 | 132 | 0.370 |
Why?
|
| Gadolinium | 4 | 2018 | 106 | 0.370 |
Why?
|
| Microvessels | 1 | 2012 | 69 | 0.370 |
Why?
|
| Statistics, Nonparametric | 6 | 2013 | 311 | 0.370 |
Why?
|
| Acute Pain | 2 | 2024 | 17 | 0.370 |
Why?
|
| Healthy Volunteers | 4 | 2017 | 157 | 0.360 |
Why?
|
| Thyroidectomy | 1 | 2012 | 173 | 0.360 |
Why?
|
| Echocardiography | 8 | 2012 | 1004 | 0.360 |
Why?
|
| Coronary Vessel Anomalies | 1 | 2012 | 43 | 0.360 |
Why?
|
| Colonography, Computed Tomographic | 2 | 2002 | 83 | 0.360 |
Why?
|
| Tomography, Spiral Computed | 4 | 2005 | 77 | 0.350 |
Why?
|
| Heart Ventricles | 6 | 2012 | 810 | 0.350 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2001 | 48 | 0.350 |
Why?
|
| Intestines | 2 | 2013 | 431 | 0.340 |
Why?
|
| Thyroid Gland | 1 | 2012 | 281 | 0.340 |
Why?
|
| Kidney Neoplasms | 5 | 2016 | 558 | 0.330 |
Why?
|
| Situs Inversus | 1 | 2010 | 15 | 0.330 |
Why?
|
| Gastrointestinal Diseases | 3 | 2013 | 154 | 0.330 |
Why?
|
| Aorta, Abdominal | 3 | 2011 | 60 | 0.330 |
Why?
|
| Neoplasms | 5 | 2020 | 3248 | 0.330 |
Why?
|
| Alagille Syndrome | 1 | 2010 | 5 | 0.330 |
Why?
|
| Pattern Recognition, Automated | 3 | 2020 | 223 | 0.320 |
Why?
|
| Coronary Vessels | 1 | 2012 | 201 | 0.320 |
Why?
|
| Surgery, Computer-Assisted | 3 | 2018 | 118 | 0.320 |
Why?
|
| Sarcoma | 3 | 2006 | 225 | 0.320 |
Why?
|
| Cellulose, Oxidized | 2 | 2000 | 4 | 0.320 |
Why?
|
| Hemangioma | 1 | 2010 | 65 | 0.320 |
Why?
|
| Defibrillators, Implantable | 4 | 2001 | 156 | 0.310 |
Why?
|
| Radiography, Abdominal | 1 | 2010 | 68 | 0.310 |
Why?
|
| Uric Acid | 1 | 2010 | 137 | 0.310 |
Why?
|
| Spleen | 1 | 2010 | 439 | 0.310 |
Why?
|
| Abdominal Injuries | 2 | 2019 | 52 | 0.300 |
Why?
|
| Penile Neoplasms | 2 | 2000 | 19 | 0.300 |
Why?
|
| Models, Biological | 5 | 2016 | 1809 | 0.300 |
Why?
|
| Enteritis | 1 | 2009 | 23 | 0.300 |
Why?
|
| Heart | 5 | 2011 | 591 | 0.300 |
Why?
|
| Jaundice | 1 | 2008 | 14 | 0.290 |
Why?
|
| Cholangitis | 1 | 2008 | 19 | 0.290 |
Why?
|
| Female Urogenital Diseases | 1 | 2008 | 9 | 0.290 |
Why?
|
| Placenta Diseases | 1 | 2008 | 13 | 0.290 |
Why?
|
| Fascioliasis | 3 | 2020 | 5 | 0.280 |
Why?
|
| Fetal Diseases | 1 | 2008 | 81 | 0.280 |
Why?
|
| Foreign Bodies | 3 | 2003 | 66 | 0.280 |
Why?
|
| Radiology Information Systems | 3 | 2020 | 78 | 0.280 |
Why?
|
| Congenital Abnormalities | 1 | 2008 | 68 | 0.280 |
Why?
|
| Testicular Neoplasms | 2 | 2022 | 123 | 0.280 |
Why?
|
| Adnexal Diseases | 1 | 2008 | 22 | 0.280 |
Why?
|
| Thyroid Neoplasms | 1 | 2012 | 443 | 0.280 |
Why?
|
| Prenatal Diagnosis | 1 | 2008 | 110 | 0.280 |
Why?
|
| Pelvic Pain | 1 | 2009 | 87 | 0.280 |
Why?
|
| Tumor Burden | 4 | 2018 | 322 | 0.270 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 279 | 0.270 |
Why?
|
| Peritoneal Neoplasms | 2 | 2016 | 187 | 0.270 |
Why?
|
| Urinary Calculi | 2 | 2004 | 46 | 0.260 |
Why?
|
| Vena Cava, Inferior | 3 | 2011 | 143 | 0.260 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2007 | 28 | 0.260 |
Why?
|
| Abdominal Neoplasms | 1 | 2007 | 40 | 0.260 |
Why?
|
| Kidney | 5 | 2015 | 1137 | 0.260 |
Why?
|
| Carotid Artery Diseases | 2 | 2005 | 103 | 0.250 |
Why?
|
| Coronary Disease | 8 | 2005 | 263 | 0.250 |
Why?
|
| Thoracic Neoplasms | 1 | 2007 | 69 | 0.250 |
Why?
|
| Metabolic Syndrome | 1 | 2008 | 123 | 0.250 |
Why?
|
| Risk Assessment | 9 | 2020 | 2480 | 0.250 |
Why?
|
| Appendectomy | 1 | 2006 | 38 | 0.250 |
Why?
|
| Heart Atria | 4 | 2016 | 290 | 0.250 |
Why?
|
| Adolescent | 21 | 2015 | 9895 | 0.240 |
Why?
|
| Rhabdomyosarcoma | 2 | 2006 | 44 | 0.240 |
Why?
|
| Pancreatitis, Chronic | 1 | 2006 | 61 | 0.240 |
Why?
|
| Response Evaluation Criteria in Solid Tumors | 2 | 2016 | 60 | 0.240 |
Why?
|
| Area Under Curve | 5 | 2016 | 340 | 0.230 |
Why?
|
| Renal Dialysis | 3 | 2008 | 364 | 0.230 |
Why?
|
| Statistics as Topic | 2 | 2016 | 236 | 0.230 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2015 | 367 | 0.230 |
Why?
|
| Radiography | 3 | 2015 | 826 | 0.220 |
Why?
|
| Estrogens, Conjugated (USP) | 2 | 2001 | 16 | 0.220 |
Why?
|
| Genital Diseases, Male | 1 | 2024 | 9 | 0.220 |
Why?
|
| Fasciola hepatica | 2 | 2020 | 4 | 0.220 |
Why?
|
| Positron Emission Tomography Computed Tomography | 2 | 2023 | 104 | 0.220 |
Why?
|
| Pancreatic Neoplasms | 2 | 2010 | 725 | 0.220 |
Why?
|
| Hydronephrosis | 1 | 2024 | 30 | 0.210 |
Why?
|
| Time | 2 | 2022 | 79 | 0.210 |
Why?
|
| Androgen Antagonists | 2 | 2023 | 144 | 0.210 |
Why?
|
| Coronary Angiography | 8 | 2010 | 261 | 0.210 |
Why?
|
| Sacrococcygeal Region | 1 | 2004 | 13 | 0.210 |
Why?
|
| Acute Disease | 6 | 2008 | 872 | 0.210 |
Why?
|
| Ventricular Fibrillation | 3 | 2001 | 70 | 0.210 |
Why?
|
| Muscular Dystrophies | 2 | 2001 | 55 | 0.210 |
Why?
|
| Kidney Failure, Chronic | 3 | 2005 | 432 | 0.210 |
Why?
|
| Colorectal Neoplasms | 2 | 2002 | 1069 | 0.210 |
Why?
|
| Endoscopy | 2 | 2011 | 374 | 0.210 |
Why?
|
| Urologic Neoplasms | 1 | 2024 | 78 | 0.200 |
Why?
|
| Iliac Vein | 1 | 2003 | 32 | 0.200 |
Why?
|
| Phantoms, Imaging | 2 | 2024 | 490 | 0.200 |
Why?
|
| Equipment Failure Analysis | 2 | 2000 | 91 | 0.200 |
Why?
|
| Stomach Neoplasms | 2 | 2003 | 310 | 0.200 |
Why?
|
| Rectal Neoplasms | 1 | 2024 | 134 | 0.200 |
Why?
|
| Water | 2 | 2023 | 307 | 0.190 |
Why?
|
| Prognosis | 10 | 2019 | 4028 | 0.190 |
Why?
|
| Angioplasty, Balloon, Coronary | 5 | 2001 | 67 | 0.190 |
Why?
|
| Urinary Tract Infections | 2 | 2020 | 85 | 0.190 |
Why?
|
| Hepatic Artery | 2 | 2000 | 84 | 0.190 |
Why?
|
| Severity of Illness Index | 2 | 2008 | 1979 | 0.190 |
Why?
|
| Stents | 4 | 2015 | 422 | 0.190 |
Why?
|
| Signal Processing, Computer-Assisted | 3 | 2000 | 205 | 0.190 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2009 | 647 | 0.190 |
Why?
|
| Follow-Up Studies | 8 | 2023 | 3927 | 0.180 |
Why?
|
| Propanolamines | 1 | 2001 | 18 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2016 | 426 | 0.180 |
Why?
|
| Radiologists | 1 | 2022 | 54 | 0.180 |
Why?
|
| Pacemaker, Artificial | 4 | 2000 | 105 | 0.180 |
Why?
|
| Carbazoles | 1 | 2001 | 31 | 0.180 |
Why?
|
| Cystadenoma | 2 | 2015 | 19 | 0.180 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2021 | 60 | 0.180 |
Why?
|
| Colonic Polyps | 1 | 2002 | 137 | 0.180 |
Why?
|
| Tunica Intima | 2 | 2005 | 61 | 0.180 |
Why?
|
| Pathologists | 1 | 2021 | 40 | 0.170 |
Why?
|
| Atrial Appendage | 1 | 2021 | 39 | 0.170 |
Why?
|
| Discriminant Analysis | 4 | 2014 | 66 | 0.170 |
Why?
|
| Endothelium, Vascular | 4 | 2008 | 437 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2001 | 110 | 0.170 |
Why?
|
| Angiography | 4 | 2011 | 209 | 0.170 |
Why?
|
| Postmenopause | 1 | 2001 | 107 | 0.170 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 1828 | 0.170 |
Why?
|
| Tunica Media | 1 | 2000 | 16 | 0.170 |
Why?
|
| Automation | 4 | 2016 | 115 | 0.170 |
Why?
|
| Datasets as Topic | 2 | 2020 | 82 | 0.170 |
Why?
|
| Carotid Artery, Common | 1 | 2000 | 28 | 0.170 |
Why?
|
| Subtraction Technique | 2 | 2013 | 130 | 0.160 |
Why?
|
| Pregnancy, Ectopic | 2 | 2012 | 37 | 0.160 |
Why?
|
| Nasturtium | 1 | 2020 | 3 | 0.160 |
Why?
|
| Antibodies, Helminth | 1 | 2020 | 10 | 0.160 |
Why?
|
| Muscular Atrophy | 1 | 2001 | 48 | 0.160 |
Why?
|
| Dyspepsia | 1 | 2020 | 9 | 0.160 |
Why?
|
| Young Adult | 6 | 2016 | 7025 | 0.160 |
Why?
|
| Adrenal Gland Diseases | 1 | 2000 | 14 | 0.160 |
Why?
|
| Granuloma, Plasma Cell | 1 | 2000 | 8 | 0.160 |
Why?
|
| Peritoneal Diseases | 1 | 2000 | 15 | 0.160 |
Why?
|
| Electric Countershock | 2 | 2001 | 64 | 0.160 |
Why?
|
| Organ Size | 3 | 2016 | 379 | 0.160 |
Why?
|
| Aortography | 1 | 2000 | 67 | 0.160 |
Why?
|
| Ventricular Function, Left | 3 | 2021 | 662 | 0.160 |
Why?
|
| Risk Factors | 12 | 2019 | 5961 | 0.160 |
Why?
|
| Documentation | 1 | 2020 | 103 | 0.150 |
Why?
|
| Eosinophilia | 1 | 2020 | 89 | 0.150 |
Why?
|
| Aneurysm | 1 | 2000 | 61 | 0.150 |
Why?
|
| Testicular Diseases | 1 | 2019 | 9 | 0.150 |
Why?
|
| Urinary Tract | 1 | 2019 | 33 | 0.150 |
Why?
|
| Analysis of Variance | 3 | 2015 | 908 | 0.150 |
Why?
|
| Wounds, Penetrating | 1 | 2019 | 56 | 0.150 |
Why?
|
| Anatomy, Cross-Sectional | 2 | 2012 | 14 | 0.150 |
Why?
|
| Urodynamics | 1 | 2019 | 130 | 0.150 |
Why?
|
| Hematoma | 1 | 2000 | 109 | 0.150 |
Why?
|
| Computer Simulation | 5 | 2021 | 1158 | 0.140 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2019 | 83 | 0.140 |
Why?
|
| Quality Control | 4 | 2019 | 125 | 0.140 |
Why?
|
| Penis | 1 | 1999 | 65 | 0.140 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2020 | 111 | 0.140 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 1998 | 74 | 0.140 |
Why?
|
| Injections, Intravenous | 2 | 2015 | 238 | 0.140 |
Why?
|
| Thalassemia | 1 | 1997 | 16 | 0.140 |
Why?
|
| Thermography | 1 | 2017 | 12 | 0.140 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1997 | 16 | 0.140 |
Why?
|
| Developing Countries | 2 | 1995 | 91 | 0.140 |
Why?
|
| Spinal Cord Compression | 1 | 1997 | 47 | 0.130 |
Why?
|
| Quality of Life | 2 | 2016 | 1816 | 0.130 |
Why?
|
| Urinary Bladder | 1 | 2019 | 263 | 0.130 |
Why?
|
| Urinary Bladder Neck Obstruction | 1 | 2017 | 26 | 0.130 |
Why?
|
| Hemospermia | 1 | 2017 | 2 | 0.130 |
Why?
|
| Muscle, Skeletal | 1 | 2001 | 483 | 0.130 |
Why?
|
| Protons | 1 | 2017 | 104 | 0.130 |
Why?
|
| Neck | 1 | 2017 | 99 | 0.130 |
Why?
|
| Fourier Analysis | 2 | 2016 | 128 | 0.130 |
Why?
|
| Reference Values | 7 | 2015 | 674 | 0.130 |
Why?
|
| Head | 1 | 2017 | 131 | 0.130 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 186 | 0.130 |
Why?
|
| Torsion Abnormality | 2 | 2008 | 18 | 0.130 |
Why?
|
| Coronary Artery Bypass | 1 | 1999 | 252 | 0.130 |
Why?
|
| Arteries | 1 | 2018 | 181 | 0.130 |
Why?
|
| Postoperative Complications | 4 | 2020 | 2591 | 0.130 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2016 | 472 | 0.130 |
Why?
|
| Penile Erection | 1 | 2016 | 22 | 0.120 |
Why?
|
| Epithelium | 2 | 2015 | 322 | 0.120 |
Why?
|
| Urination | 1 | 2016 | 41 | 0.120 |
Why?
|
| Pancreatic Cyst | 2 | 2010 | 29 | 0.120 |
Why?
|
| Combined Modality Therapy | 2 | 2018 | 1773 | 0.120 |
Why?
|
| Internationality | 1 | 2016 | 76 | 0.120 |
Why?
|
| Myocardial Infarction | 4 | 2007 | 429 | 0.120 |
Why?
|
| Age Factors | 5 | 2017 | 1963 | 0.120 |
Why?
|
| Endpoint Determination | 1 | 2016 | 59 | 0.120 |
Why?
|
| Cholangiography | 2 | 2013 | 38 | 0.120 |
Why?
|
| Multidetector Computed Tomography | 1 | 2016 | 61 | 0.120 |
Why?
|
| Pathology | 1 | 2015 | 36 | 0.120 |
Why?
|
| Atrophy | 1 | 2015 | 131 | 0.110 |
Why?
|
| Tachycardia, Ventricular | 4 | 2001 | 132 | 0.110 |
Why?
|
| Urination Disorders | 1 | 2015 | 56 | 0.110 |
Why?
|
| Case-Control Studies | 6 | 2011 | 1957 | 0.110 |
Why?
|
| Genital Neoplasms, Female | 1 | 2016 | 115 | 0.110 |
Why?
|
| Clinical Competence | 1 | 2020 | 854 | 0.110 |
Why?
|
| Syncope | 3 | 2013 | 37 | 0.110 |
Why?
|
| Models, Animal | 1 | 2015 | 286 | 0.110 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 299 | 0.110 |
Why?
|
| Sulfonamides | 1 | 2016 | 337 | 0.110 |
Why?
|
| Cognition | 1 | 2019 | 635 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 445 | 0.100 |
Why?
|
| Bile Duct Diseases | 1 | 2013 | 23 | 0.100 |
Why?
|
| Pyrimidines | 1 | 2016 | 386 | 0.100 |
Why?
|
| Homocysteine | 3 | 2005 | 30 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 3 | 2017 | 3489 | 0.100 |
Why?
|
| Logistic Models | 3 | 2010 | 1268 | 0.100 |
Why?
|
| Models, Anatomic | 1 | 2013 | 93 | 0.100 |
Why?
|
| Timolol | 1 | 2013 | 1 | 0.100 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2013 | 11 | 0.100 |
Why?
|
| Patient Selection | 2 | 2019 | 709 | 0.100 |
Why?
|
| Time Factors | 7 | 2016 | 5580 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 276 | 0.100 |
Why?
|
| Echinococcosis, Hepatic | 1 | 2012 | 3 | 0.100 |
Why?
|
| Myocardial Ischemia | 3 | 2000 | 167 | 0.100 |
Why?
|
| Motion | 2 | 2024 | 99 | 0.100 |
Why?
|
| Living Donors | 2 | 2016 | 348 | 0.100 |
Why?
|
| Foramen Ovale, Patent | 1 | 2013 | 24 | 0.100 |
Why?
|
| Bradycardia | 1 | 2013 | 45 | 0.100 |
Why?
|
| Triage | 2 | 2016 | 132 | 0.100 |
Why?
|
| Intracranial Embolism | 1 | 2013 | 30 | 0.100 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2004 | 85 | 0.100 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 231 | 0.090 |
Why?
|
| Heart Conduction System | 5 | 2000 | 126 | 0.090 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 191 | 0.090 |
Why?
|
| Genome | 1 | 2015 | 407 | 0.090 |
Why?
|
| Microcirculation | 1 | 2012 | 104 | 0.090 |
Why?
|
| Turkey | 5 | 2011 | 22 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2000 | 1230 | 0.090 |
Why?
|
| Rectum | 1 | 2013 | 151 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 484 | 0.090 |
Why?
|
| Cohort Studies | 3 | 2016 | 3110 | 0.090 |
Why?
|
| Cardiovascular Diseases | 3 | 2005 | 777 | 0.090 |
Why?
|
| Catheterization, Central Venous | 1 | 1993 | 120 | 0.090 |
Why?
|
| Research Design | 2 | 2013 | 631 | 0.090 |
Why?
|
| Neoplasm Metastasis | 3 | 2020 | 1094 | 0.090 |
Why?
|
| Intestinal Fistula | 1 | 2011 | 31 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 298 | 0.090 |
Why?
|
| Urology | 1 | 2013 | 133 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2011 | 81 | 0.090 |
Why?
|
| Ascites | 1 | 2011 | 57 | 0.090 |
Why?
|
| Heart Failure | 1 | 2001 | 1422 | 0.090 |
Why?
|
| Animals | 9 | 2020 | 28891 | 0.090 |
Why?
|
| Salvage Therapy | 1 | 2012 | 238 | 0.090 |
Why?
|
| Diffusion | 1 | 2011 | 95 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2004 | 599 | 0.080 |
Why?
|
| Leiomyoma | 1 | 2014 | 211 | 0.080 |
Why?
|
| Mesenteric Veins | 2 | 2001 | 36 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2014 | 258 | 0.080 |
Why?
|
| Ileum | 1 | 2011 | 169 | 0.080 |
Why?
|
| Cardiomyopathies | 2 | 2005 | 286 | 0.080 |
Why?
|
| Uterine Neoplasms | 1 | 2014 | 278 | 0.080 |
Why?
|
| Vasodilation | 2 | 2008 | 96 | 0.080 |
Why?
|
| Thrombosis | 1 | 2013 | 326 | 0.080 |
Why?
|
| Cystography | 2 | 2019 | 6 | 0.080 |
Why?
|
| Incidence | 4 | 2016 | 1715 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2014 | 340 | 0.080 |
Why?
|
| Syndrome | 1 | 2010 | 453 | 0.080 |
Why?
|
| Rectal Fistula | 1 | 2009 | 19 | 0.080 |
Why?
|
| Arteriovenous Fistula | 2 | 2000 | 54 | 0.080 |
Why?
|
| Biliary Fistula | 1 | 2009 | 11 | 0.080 |
Why?
|
| Respiratory Tract Fistula | 1 | 2009 | 9 | 0.080 |
Why?
|
| Body Patterning | 1 | 2011 | 217 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2011 | 235 | 0.070 |
Why?
|
| Heart Diseases | 2 | 2002 | 314 | 0.070 |
Why?
|
| Sphincterotomy, Endoscopic | 1 | 2008 | 8 | 0.070 |
Why?
|
| Azygos Vein | 1 | 2008 | 4 | 0.070 |
Why?
|
| Medical Oncology | 1 | 2013 | 408 | 0.070 |
Why?
|
| Death, Sudden, Cardiac | 2 | 1999 | 61 | 0.070 |
Why?
|
| Hypertrophy, Left Ventricular | 3 | 2005 | 76 | 0.070 |
Why?
|
| Liver Transplantation | 2 | 2016 | 1201 | 0.070 |
Why?
|
| Rheumatic Heart Disease | 2 | 2001 | 32 | 0.070 |
Why?
|
| Antiplatyhelmintic Agents | 3 | 2020 | 5 | 0.070 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 3157 | 0.070 |
Why?
|
| E-Selectin | 2 | 2005 | 31 | 0.070 |
Why?
|
| Child | 11 | 2003 | 7625 | 0.070 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2005 | 58 | 0.070 |
Why?
|
| Hemorrhage | 2 | 2008 | 294 | 0.070 |
Why?
|
| Body Constitution | 1 | 2008 | 26 | 0.070 |
Why?
|
| Brachial Artery | 1 | 2008 | 36 | 0.070 |
Why?
|
| Intercellular Adhesion Molecule-1 | 2 | 2005 | 76 | 0.070 |
Why?
|
| Hypertension | 4 | 2011 | 774 | 0.070 |
Why?
|
| Endometriosis | 1 | 2008 | 63 | 0.070 |
Why?
|
| Teratoma | 1 | 2008 | 58 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 710 | 0.070 |
Why?
|
| Emergencies | 3 | 2004 | 124 | 0.070 |
Why?
|
| Atrial Flutter | 2 | 2005 | 37 | 0.070 |
Why?
|
| Renal Insufficiency | 1 | 2008 | 99 | 0.070 |
Why?
|
| Forecasting | 1 | 2008 | 317 | 0.070 |
Why?
|
| Gestational Trophoblastic Disease | 1 | 2007 | 2 | 0.070 |
Why?
|
| Mice | 3 | 2020 | 12537 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 594 | 0.070 |
Why?
|
| Diastole | 3 | 2002 | 147 | 0.070 |
Why?
|
| Colitis | 1 | 2010 | 262 | 0.060 |
Why?
|
| Administration, Oral | 5 | 2016 | 688 | 0.060 |
Why?
|
| Enterocolitis, Neutropenic | 1 | 2006 | 1 | 0.060 |
Why?
|
| Cystadenocarcinoma | 1 | 2006 | 12 | 0.060 |
Why?
|
| Adenoma, Oxyphilic | 2 | 2004 | 38 | 0.060 |
Why?
|
| Odontoid Process | 1 | 2006 | 3 | 0.060 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2006 | 68 | 0.060 |
Why?
|
| Torticollis | 1 | 2006 | 12 | 0.060 |
Why?
|
| Skin Diseases | 1 | 2008 | 176 | 0.060 |
Why?
|
| Osteomyelitis | 1 | 2006 | 57 | 0.060 |
Why?
|
| Neutropenia | 1 | 2006 | 218 | 0.060 |
Why?
|
| Venous Thrombosis | 1 | 2008 | 257 | 0.060 |
Why?
|
| Bile Duct Neoplasms | 1 | 2006 | 91 | 0.060 |
Why?
|
| Laryngoscopy | 1 | 2006 | 50 | 0.060 |
Why?
|
| Diarrhea | 1 | 2006 | 181 | 0.060 |
Why?
|
| Infant | 5 | 2006 | 3363 | 0.060 |
Why?
|
| Consensus | 2 | 2021 | 370 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 2534 | 0.060 |
Why?
|
| Laryngeal Neoplasms | 1 | 2006 | 89 | 0.060 |
Why?
|
| Pelvic Inflammatory Disease | 1 | 2004 | 9 | 0.060 |
Why?
|
| Biomarkers | 3 | 2018 | 1930 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 1973 | 0.060 |
Why?
|
| Central Nervous System Diseases | 1 | 2005 | 51 | 0.060 |
Why?
|
| Ovarian Diseases | 1 | 2004 | 32 | 0.060 |
Why?
|
| Inflammation | 1 | 2011 | 1063 | 0.060 |
Why?
|
| Dura Mater | 1 | 2005 | 51 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 1876 | 0.050 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2004 | 2 | 0.050 |
Why?
|
| Sex Characteristics | 2 | 2004 | 339 | 0.050 |
Why?
|
| Genital Diseases, Female | 1 | 2004 | 24 | 0.050 |
Why?
|
| Electrodes, Implanted | 3 | 2000 | 219 | 0.050 |
Why?
|
| Electronics, Medical | 1 | 2004 | 4 | 0.050 |
Why?
|
| Biliary Tract Diseases | 1 | 2004 | 37 | 0.050 |
Why?
|
| X-Ray Film | 1 | 2004 | 37 | 0.050 |
Why?
|
| Adrenal Glands | 2 | 2004 | 78 | 0.050 |
Why?
|
| Pelvis | 2 | 2003 | 103 | 0.050 |
Why?
|
| Heart Septal Defects, Atrial | 2 | 2005 | 73 | 0.050 |
Why?
|
| Vascular Diseases | 1 | 2005 | 123 | 0.050 |
Why?
|
| Pulmonary Veins | 1 | 2005 | 96 | 0.050 |
Why?
|
| Bone Diseases | 1 | 2004 | 54 | 0.050 |
Why?
|
| Watchful Waiting | 1 | 2024 | 71 | 0.050 |
Why?
|
| Laboratories | 1 | 2004 | 48 | 0.050 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2007 | 319 | 0.050 |
Why?
|
| Positron-Emission Tomography | 2 | 2019 | 353 | 0.050 |
Why?
|
| Pelvic Bones | 1 | 2004 | 45 | 0.050 |
Why?
|
| Stroke | 1 | 2013 | 1087 | 0.050 |
Why?
|
| Radionuclide Imaging | 1 | 2004 | 217 | 0.050 |
Why?
|
| Craniofacial Abnormalities | 1 | 2003 | 35 | 0.050 |
Why?
|
| Carcinoid Tumor | 1 | 2003 | 46 | 0.050 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2024 | 204 | 0.050 |
Why?
|
| Pulmonary Artery | 1 | 2005 | 341 | 0.050 |
Why?
|
| Europe | 2 | 2020 | 349 | 0.050 |
Why?
|
| Leiomyosarcoma | 1 | 2003 | 49 | 0.050 |
Why?
|
| Urography | 1 | 2002 | 41 | 0.050 |
Why?
|
| Thromboembolism | 2 | 2001 | 128 | 0.050 |
Why?
|
| Heparin | 2 | 2001 | 186 | 0.050 |
Why?
|
| Hepatolenticular Degeneration | 1 | 2002 | 19 | 0.050 |
Why?
|
| Tuberculosis, Cardiovascular | 1 | 2002 | 1 | 0.050 |
Why?
|
| Cystectomy | 2 | 2019 | 114 | 0.050 |
Why?
|
| Melanoma | 1 | 2007 | 497 | 0.050 |
Why?
|
| Schools, Medical | 1 | 2004 | 144 | 0.050 |
Why?
|
| Torsades de Pointes | 1 | 2002 | 7 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2005 | 267 | 0.050 |
Why?
|
| Bronchi | 1 | 2003 | 234 | 0.050 |
Why?
|
| Trachea | 1 | 2003 | 293 | 0.050 |
Why?
|
| Gastroscopy | 1 | 2002 | 25 | 0.050 |
Why?
|
| Oxides | 1 | 2002 | 44 | 0.050 |
Why?
|
| Portal Vein | 2 | 2000 | 122 | 0.050 |
Why?
|
| Orbital Pseudotumor | 1 | 2001 | 1 | 0.050 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2013 | 647 | 0.050 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 2001 | 6 | 0.050 |
Why?
|
| Soybean Proteins | 1 | 2001 | 5 | 0.050 |
Why?
|
| Cavernous Sinus | 1 | 2001 | 15 | 0.050 |
Why?
|
| Bronchoscopy | 1 | 2003 | 178 | 0.040 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2001 | 20 | 0.040 |
Why?
|
| Recurrence | 3 | 1999 | 1218 | 0.040 |
Why?
|
| Linear Models | 2 | 2014 | 438 | 0.040 |
Why?
|
| Lymphoma | 1 | 2003 | 271 | 0.040 |
Why?
|
| Child, Preschool | 5 | 2003 | 3974 | 0.040 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2001 | 3 | 0.040 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2022 | 58 | 0.040 |
Why?
|
| Iron | 1 | 2002 | 179 | 0.040 |
Why?
|
| Ovarian Neoplasms | 1 | 2008 | 801 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2005 | 829 | 0.040 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2001 | 23 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2004 | 323 | 0.040 |
Why?
|
| Pain | 1 | 2004 | 426 | 0.040 |
Why?
|
| Endocarditis | 1 | 2001 | 25 | 0.040 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2001 | 18 | 0.040 |
Why?
|
| Hypertension, Pulmonary | 1 | 2005 | 381 | 0.040 |
Why?
|
| Endocarditis, Bacterial | 1 | 2001 | 39 | 0.040 |
Why?
|
| Echocardiography, Doppler | 1 | 2002 | 193 | 0.040 |
Why?
|
| Cytokines | 1 | 2005 | 871 | 0.040 |
Why?
|
| Phosphorylcholine | 1 | 2001 | 27 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2002 | 196 | 0.040 |
Why?
|
| Central Nervous System Cysts | 1 | 2000 | 10 | 0.040 |
Why?
|
| Thigh | 1 | 2001 | 41 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2001 | 304 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2024 | 449 | 0.040 |
Why?
|
| Choristoma | 1 | 2001 | 63 | 0.040 |
Why?
|
| Kidney Transplantation | 2 | 2005 | 882 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2001 | 161 | 0.040 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2000 | 7 | 0.040 |
Why?
|
| Duodenum | 1 | 2001 | 112 | 0.040 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2001 | 110 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2001 | 206 | 0.040 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2002 | 121 | 0.040 |
Why?
|
| Laminin | 1 | 2000 | 92 | 0.040 |
Why?
|
| Life Cycle Stages | 1 | 2020 | 16 | 0.040 |
Why?
|
| Women's Health | 1 | 2001 | 109 | 0.040 |
Why?
|
| Blood Platelets | 1 | 2001 | 156 | 0.040 |
Why?
|
| Mice, Inbred C3H | 1 | 2020 | 372 | 0.040 |
Why?
|
| Canada | 1 | 2020 | 215 | 0.040 |
Why?
|
| Adenoma | 1 | 2002 | 260 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 1998 | 595 | 0.040 |
Why?
|
| Travel | 1 | 2020 | 72 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 363 | 0.040 |
Why?
|
| Cystoscopy | 1 | 2019 | 37 | 0.040 |
Why?
|
| Indicator Dilution Techniques | 1 | 2019 | 9 | 0.040 |
Why?
|
| Bundle-Branch Block | 1 | 2000 | 61 | 0.040 |
Why?
|
| Cryosurgery | 1 | 2000 | 65 | 0.040 |
Why?
|
| Intellectual Disability | 1 | 2000 | 203 | 0.040 |
Why?
|
| Ultrasonography, Doppler | 1 | 2019 | 83 | 0.040 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 2001 | 208 | 0.040 |
Why?
|
| Fibrosis | 2 | 2013 | 235 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2002 | 340 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2019 | 154 | 0.040 |
Why?
|
| Support Vector Machine | 1 | 2019 | 25 | 0.040 |
Why?
|
| Cerebellum | 1 | 2000 | 253 | 0.040 |
Why?
|
| Thallium Radioisotopes | 1 | 1998 | 5 | 0.040 |
Why?
|
| Abscess | 1 | 1999 | 95 | 0.040 |
Why?
|
| Kallikreins | 1 | 2019 | 46 | 0.040 |
Why?
|
| Urethra | 1 | 2019 | 115 | 0.040 |
Why?
|
| Accidents, Traffic | 1 | 2000 | 104 | 0.040 |
Why?
|
| Dobutamine | 1 | 1998 | 62 | 0.040 |
Why?
|
| Anticoagulants | 2 | 2000 | 463 | 0.040 |
Why?
|
| Artifacts | 1 | 2000 | 252 | 0.040 |
Why?
|
| Unnecessary Procedures | 1 | 2019 | 55 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2019 | 136 | 0.040 |
Why?
|
| Cerebrovascular Disorders | 1 | 1999 | 146 | 0.040 |
Why?
|
| Postoperative Period | 1 | 1999 | 318 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2000 | 166 | 0.040 |
Why?
|
| Diabetic Neuropathies | 1 | 1998 | 41 | 0.030 |
Why?
|
| Aging | 1 | 2003 | 766 | 0.030 |
Why?
|
| Monitoring, Physiologic | 1 | 2019 | 273 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 1998 | 95 | 0.030 |
Why?
|
| Pancreas Transplantation | 1 | 1998 | 105 | 0.030 |
Why?
|
| Prostatic Diseases | 1 | 2017 | 3 | 0.030 |
Why?
|
| Digital Rectal Examination | 1 | 2017 | 5 | 0.030 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 1 | 2017 | 30 | 0.030 |
Why?
|
| Elective Surgical Procedures | 1 | 1998 | 162 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2000 | 815 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1998 | 180 | 0.030 |
Why?
|
| Iohexol | 2 | 2011 | 23 | 0.030 |
Why?
|
| Estradiol | 1 | 2017 | 255 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 514 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 1999 | 300 | 0.030 |
Why?
|
| Radiotherapy | 1 | 2018 | 328 | 0.030 |
Why?
|
| Spinal Cord | 1 | 1997 | 252 | 0.030 |
Why?
|
| Indazoles | 1 | 2016 | 61 | 0.030 |
Why?
|
| Temperature | 1 | 2017 | 426 | 0.030 |
Why?
|
| Fibrinolytic Agents | 2 | 2013 | 240 | 0.030 |
Why?
|
| Bithionol | 2 | 2006 | 2 | 0.030 |
Why?
|
| Chronic Disease | 1 | 1999 | 983 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2015 | 119 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1997 | 351 | 0.030 |
Why?
|
| Physical Examination | 1 | 2016 | 154 | 0.030 |
Why?
|
| Spin Labels | 1 | 2015 | 107 | 0.030 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1995 | 27 | 0.030 |
Why?
|
| Equipment Reuse | 1 | 1995 | 9 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2017 | 514 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 489 | 0.030 |
Why?
|
| Mitral Valve Stenosis | 1 | 1995 | 38 | 0.030 |
Why?
|
| Thermal Conductivity | 1 | 2014 | 3 | 0.030 |
Why?
|
| Cost Savings | 1 | 1995 | 71 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 1982 | 771 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 319 | 0.030 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 1995 | 111 | 0.030 |
Why?
|
| Breast | 1 | 2016 | 297 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2007 | 2463 | 0.030 |
Why?
|
| Organ Sparing Treatments | 1 | 2014 | 47 | 0.030 |
Why?
|
| Catheterization | 1 | 1995 | 238 | 0.030 |
Why?
|
| Dilatation, Pathologic | 2 | 2005 | 55 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2018 | 441 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2016 | 1196 | 0.020 |
Why?
|
| Kinetics | 1 | 2016 | 1562 | 0.020 |
Why?
|
| Administration, Ophthalmic | 1 | 2013 | 8 | 0.020 |
Why?
|
| Laparoscopy | 1 | 2000 | 784 | 0.020 |
Why?
|
| Blood Pressure | 3 | 2011 | 926 | 0.020 |
Why?
|
| Sick Sinus Syndrome | 1 | 1993 | 9 | 0.020 |
Why?
|
| Pregnancy, Heterotopic | 1 | 2012 | 3 | 0.020 |
Why?
|
| Pregnancy, Abdominal | 1 | 2012 | 5 | 0.020 |
Why?
|
| Administration, Topical | 1 | 2013 | 86 | 0.020 |
Why?
|
| Echinococcosis | 1 | 2012 | 5 | 0.020 |
Why?
|
| Brain | 1 | 2023 | 2482 | 0.020 |
Why?
|
| Fallopian Tubes | 1 | 2012 | 49 | 0.020 |
Why?
|
| Stroke Volume | 2 | 2008 | 531 | 0.020 |
Why?
|
| Reference Standards | 1 | 2013 | 150 | 0.020 |
Why?
|
| Checklist | 1 | 2013 | 72 | 0.020 |
Why?
|
| Cicatrix | 1 | 2012 | 72 | 0.020 |
Why?
|
| Cadmium | 1 | 1992 | 30 | 0.020 |
Why?
|
| Disease Progression | 1 | 2016 | 1562 | 0.020 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2005 | 362 | 0.020 |
Why?
|
| Cesarean Section | 1 | 2012 | 157 | 0.020 |
Why?
|
| Rats | 1 | 2017 | 4155 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2013 | 245 | 0.020 |
Why?
|
| Renal Artery | 1 | 2011 | 46 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2011 | 363 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2013 | 276 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 1991 | 152 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2013 | 264 | 0.020 |
Why?
|
| Cystadenoma, Mucinous | 1 | 2010 | 7 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2016 | 1179 | 0.020 |
Why?
|
| Cystadenoma, Serous | 1 | 2010 | 16 | 0.020 |
Why?
|
| Cystadenoma, Papillary | 1 | 2010 | 9 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 2011 | 219 | 0.020 |
Why?
|
| Patient Safety | 1 | 2013 | 223 | 0.020 |
Why?
|
| Nifedipine | 1 | 1990 | 26 | 0.020 |
Why?
|
| Captopril | 1 | 1990 | 23 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 1990 | 39 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1753 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2013 | 695 | 0.020 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2010 | 68 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2009 | 68 | 0.020 |
Why?
|
| Prazosin | 1 | 1988 | 9 | 0.020 |
Why?
|
| Digoxin | 1 | 1988 | 21 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2008 | 197 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2008 | 297 | 0.020 |
Why?
|
| Smoking | 1 | 1992 | 653 | 0.020 |
Why?
|
| Angina, Unstable | 2 | 2001 | 6 | 0.020 |
Why?
|
| Tachycardia | 2 | 2001 | 36 | 0.020 |
Why?
|
| Software | 1 | 2011 | 698 | 0.020 |
Why?
|
| Desmin | 1 | 2006 | 10 | 0.020 |
Why?
|
| Myogenin | 1 | 2006 | 5 | 0.020 |
Why?
|
| Keratins | 1 | 2006 | 63 | 0.020 |
Why?
|
| Abdominal Wall | 1 | 2006 | 32 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2006 | 226 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2006 | 94 | 0.020 |
Why?
|
| Angina Pectoris | 2 | 1999 | 29 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 2005 | 30 | 0.010 |
Why?
|
| Heart Septum | 1 | 2005 | 47 | 0.010 |
Why?
|
| Phosphates | 1 | 2005 | 167 | 0.010 |
Why?
|
| Spinal Fractures | 1 | 2006 | 103 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2005 | 112 | 0.010 |
Why?
|
| Heart Block | 2 | 1997 | 32 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 380 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 433 | 0.010 |
Why?
|
| Pedigree | 2 | 2000 | 982 | 0.010 |
Why?
|
| CD-ROM | 1 | 2004 | 3 | 0.010 |
Why?
|
| Carotid Arteries | 1 | 2005 | 136 | 0.010 |
Why?
|
| Hemodynamics | 2 | 2000 | 775 | 0.010 |
Why?
|
| Heart Valve Diseases | 1 | 2005 | 121 | 0.010 |
Why?
|
| Cervical Vertebrae | 1 | 2006 | 232 | 0.010 |
Why?
|
| Problem-Based Learning | 1 | 2004 | 40 | 0.010 |
Why?
|
| Inhalation | 1 | 2003 | 34 | 0.010 |
Why?
|
| Feces | 1 | 2005 | 360 | 0.010 |
Why?
|
| Computer-Assisted Instruction | 1 | 2004 | 48 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 4374 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2005 | 349 | 0.010 |
Why?
|
| Mitral Valve | 1 | 2005 | 279 | 0.010 |
Why?
|
| Ferrosoferric Oxide | 1 | 2002 | 19 | 0.010 |
Why?
|
| Magnetite Nanoparticles | 1 | 2002 | 27 | 0.010 |
Why?
|
| Dextrans | 1 | 2002 | 78 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 2002 | 33 | 0.010 |
Why?
|
| Thrombomodulin | 1 | 2001 | 9 | 0.010 |
Why?
|
| Sheep | 1 | 2002 | 250 | 0.010 |
Why?
|
| Systole | 1 | 1982 | 116 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2005 | 713 | 0.010 |
Why?
|
| Prolactin | 1 | 2001 | 89 | 0.010 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2001 | 147 | 0.010 |
Why?
|
| Luteinizing Hormone | 1 | 2001 | 169 | 0.010 |
Why?
|
| Body Height | 1 | 2002 | 108 | 0.010 |
Why?
|
| Lymph Node Excision | 1 | 2003 | 235 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2001 | 69 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2001 | 48 | 0.010 |
Why?
|
| P-Selectin | 1 | 2001 | 14 | 0.010 |
Why?
|
| Probability | 1 | 2002 | 365 | 0.010 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2004 | 189 | 0.010 |
Why?
|
| Glucose Tolerance Test | 1 | 2001 | 235 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2005 | 594 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2001 | 138 | 0.010 |
Why?
|
| Triglycerides | 1 | 2001 | 235 | 0.010 |
Why?
|
| Calcium | 1 | 2005 | 1205 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2001 | 173 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2001 | 60 | 0.010 |
Why?
|
| Heart Valve Prosthesis | 1 | 2001 | 106 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 2001 | 121 | 0.010 |
Why?
|
| Genotype | 1 | 2005 | 1881 | 0.010 |
Why?
|
| Death | 1 | 2001 | 97 | 0.010 |
Why?
|
| Body Weight | 1 | 2002 | 460 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2002 | 1010 | 0.010 |
Why?
|
| Atrial Function, Left | 1 | 2000 | 54 | 0.010 |
Why?
|
| Cardiac Output | 1 | 2000 | 159 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 2000 | 43 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2001 | 176 | 0.010 |
Why?
|
| Cholesterol, LDL | 1 | 2001 | 246 | 0.010 |
Why?
|
| Angiomyolipoma | 1 | 2000 | 17 | 0.010 |
Why?
|
| Lipids | 1 | 2001 | 285 | 0.010 |
Why?
|
| Electrophysiology | 2 | 1991 | 406 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2006 | 1667 | 0.010 |
Why?
|
| Supine Position | 1 | 1999 | 34 | 0.010 |
Why?
|
| Long-Term Care | 1 | 2000 | 63 | 0.010 |
Why?
|
| Cholesterol | 1 | 2001 | 369 | 0.010 |
Why?
|
| Warfarin | 1 | 2000 | 107 | 0.010 |
Why?
|
| Posture | 1 | 1999 | 130 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2000 | 623 | 0.010 |
Why?
|
| Disease Management | 1 | 2001 | 360 | 0.010 |
Why?
|
| Device Removal | 1 | 2000 | 166 | 0.010 |
Why?
|
| Ticlopidine | 1 | 1998 | 26 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2001 | 261 | 0.010 |
Why?
|
| Sex Factors | 1 | 2002 | 1133 | 0.010 |
Why?
|
| Students, Medical | 1 | 2004 | 455 | 0.010 |
Why?
|
| Biosensing Techniques | 1 | 1999 | 81 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2000 | 740 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2000 | 1010 | 0.010 |
Why?
|
| Arterial Occlusive Diseases | 1 | 1998 | 111 | 0.010 |
Why?
|
| Comorbidity | 1 | 2001 | 1011 | 0.010 |
Why?
|
| Risk | 1 | 1999 | 668 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2000 | 1083 | 0.010 |
Why?
|
| Prevalence | 1 | 2001 | 1349 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2001 | 873 | 0.010 |
Why?
|
| Aspirin | 1 | 1998 | 169 | 0.010 |
Why?
|
| Electric Impedance | 1 | 1997 | 112 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1998 | 813 | 0.010 |
Why?
|
| Insulin | 1 | 2001 | 1190 | 0.010 |
Why?
|
| Radionuclide Ventriculography | 1 | 1996 | 3 | 0.010 |
Why?
|
| Thallium | 1 | 1996 | 8 | 0.010 |
Why?
|
| Equipment Design | 1 | 1997 | 427 | 0.010 |
Why?
|
| Registries | 1 | 2001 | 986 | 0.010 |
Why?
|
| Fetal Monitoring | 1 | 1995 | 19 | 0.010 |
Why?
|
| Heart Rate, Fetal | 1 | 1995 | 16 | 0.010 |
Why?
|
| Proteins | 1 | 2000 | 816 | 0.010 |
Why?
|
| Brain Ischemia | 1 | 1999 | 416 | 0.010 |
Why?
|
| Gestational Age | 1 | 1995 | 343 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2000 | 1276 | 0.010 |
Why?
|
| Sinoatrial Node | 1 | 1993 | 12 | 0.010 |
Why?
|
| Surveys and Questionnaires | 1 | 2001 | 2860 | 0.010 |
Why?
|
| Bundle of His | 1 | 1993 | 53 | 0.010 |
Why?
|
| Gated Blood-Pool Imaging | 1 | 1991 | 8 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1991 | 228 | 0.010 |
Why?
|
| Diabetic Retinopathy | 1 | 1991 | 82 | 0.010 |
Why?
|
| Pindolol | 1 | 1990 | 6 | 0.010 |
Why?
|
| Eosinophils | 1 | 1991 | 199 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1991 | 253 | 0.010 |
Why?
|
| Administration, Sublingual | 1 | 1990 | 6 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1995 | 2614 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1988 | 245 | 0.000 |
Why?
|